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Background: Most of the studies characterizing the incidence of rhinovirus (RV) have been carried out in hospitalized
children and in developed countries. In those studies, RV-C has been associated with more severe respiratory tract
infections than RV species A and B. In this study we determined the frequency and diversity of RV strains associated
with upper and lower respiratory tract infections (URTI, LRTI) in Mexico, and describe the clinical characteristics of the
illness associated with different RV species.
Methods: A prospective surveillance of 526 and 250 children with URTI and LRTI was carried out. Respiratory samples
were analyzed by RT-PCR for viruses. The 5′ untranslated region of the RV genome was amplified and sequenced.
Results: In the case of URTI, 17.5% were positive for RV, while this virus was found in 24.8% of LRTI. The RV species was
determined in 73 children with URTI: 61.6% were RV-A, 37% RV-C and, 1.4% RV-B; and in 43 children with LRTI: 51.2%
were RV-A, 41.8% RV-C, and 7% RV-B. No significant differences in clinical characteristics were found in patients with
RV-A or RV-C infections. A high genetic diversity of RV strains was found in both URTI and LRTI.
Conclusions: Both RV-A and RV-C species were frequently found in hospitalized as well as in outpatient children. This
study underlines the high prevalence and genetic diversity of RV strains in Mexico and the potential severity of disease
associated with RV-A and RV-C infections.
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Pneumonia continues to be a major killer of young children
in developing countries and elderly people in developed
countries. Despite recent advances, further studies are
needed to examine regional variation in its etiology,
particularly in developing countries, where most of the
deaths from serious respiratory diseases occur [1,2].
Rhinovirus (RV) is the most frequent cause of acute
respiratory illness worldwide [3-5]. This virus has been* Correspondence: arias@ibt.unam.mx
†Equal contributors
1Instituto de Biotecnología, Universidad Nacional Autónoma de México, Av.
Universidad 2001, Colonia Chamilpa, Cuernavaca, Morelos 62210, Mexico
Full list of author information is available at the end of the article
© 2015 Aponte et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.typically associated with upper respiratory tract infections
(URTI); however, with the development of molecular
methods RV has been found to be also commonly associ-
ated with lower respiratory tract infections (LRTI). These
findings are changing the long held view of RV as a minor
pathogen, as it is now being involved in a wide variety of
respiratory illnesses, ranging from mild common colds
and asthma exacerbation to serious lower respiratory tract
disease [3-5].
RVs are antigenically quite diverse; historically, these
viruses were classified into 99 serotypes through
neutralization assays. These different RV serotypes were
later classified genotypically into two species, RV-A (74
serotypes/genotypes) and RV-B (25 serotypes/genotypes). This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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information, a third virus species, RV-C, was described
[6-9]. The current genotypification of these viruses is
based on the nucleotide sequence encoding the VP1 and
VP4/VP2 proteins [3]. Nevertheless, a variable region in
the 5′-untranslated region (UTR) of the viral genome
can also accurately distinguish among virus species [10].
Since its description in 2006, RV-C was suggested to be
associated with more severe respiratory illness as com-
pared to RV-A and RV-B, as well as with more frequent
asthma exacerbations [11-16]. However, other studies
have found no difference in illness severity among RV
species [17-20], thus, more information is needed to
clarify this issue.
Most studies have described the presence of RV geno-
types in hospitalized patients with severe respiratory illness,
and only a few studies have described the prevalence of
virus genotypes in URTIs. In this work, we carried out a
prospective multicenter study of two children populations
having either URTI or LRTI.
Results
RV detection
Nasopharyngeal samples from 526 pediatric patients with
URTI attending the private consult were tested for the
presence of RV and other respiratory viruses. Ninety-two
(17.5%) children (47 males and 45 females, age range 0 to
175 months) were RV positive. The species of 73 (80.2%)
of these RVs was determined by sequencing the 5′-UTR
region of the viral genome; 45 (61.6%) were RV-A, 27
(37%) RV-C, and 1 (1.4%) was RV-B (Table 1). The
incidence of RV infection was highest in September
and November 2011 as well as in April 2012, when it
accounted for 24.4%, 27.1% and 30.3%, respectively, of
the total samples collected (Figure 1).
On the other hand, 250 hospitalized children with
clinical diagnosis suggestive of viral pneumonia were
included in the study. Nasal washings were obtained and
tested for the presence of respiratory viruses. Sixty-two
children (41 males and 21 females, age range 1 to
76 months) were positive for RV (24.8%). The species of 43
(69.4%) of these viruses was determined by sequencing the
5'-UTR region of the viral genome. Of the typed viruses,
22 (51.2%) were RV-A, 18 (41.8%) RV-C, and 3 (7%) were
RV-B (Table 1). The difference in the incidence of RV-A
and RV-C was not statistically significant. RV-positive
children were detected more frequently (p < 0.0001) in
children between 25 and 36 months as compared to the
other age groups (Table 1). There was no significant
gender between children infected with RV or another re-
spiratory virus or between RV-A and RV-C. Hospitalization
for RV was significantly higher (p < 0.0001) in the spring as
compared to other seasons.Co-infection of RV with other respiratory viruses
An additional respiratory virus was found in 30% (28/92)
and 37% (23/62) of RV-positive patients with URTI and
LRTI, respectively (Table 1). The virus species could be
determined in 19 (14 RV-A, 5 RV-C) and 14 (7 RV-A, 1
RV-B, 6 RV-C) of URTI and LRTI mixed infections,
respectively. Neither RV-A nor RV-C types were signifi-
cantly associated with a particular respiratory virus in
mixed infections of URTI or LRTI. However, in URTI,
RV-A was found more frequently in co-infections than
RV-C (p = 0.025). In both children populations, when
RV was present in mixed infections, it was more fre-
quently found associated with a single virus (URTI, 20/
28; LRTI, 21/23) than with 2 other viruses (URTI, 8/28;
LRTI, 2/23) (URTI p = 0.014, LRTI p < 0.0001).
Clinical characteristics of RV-positive children
The major symptoms and signs observed in children with
RV-associated URTI in single or mixed infections were
cough, rhinorrhea, and sore throat. However, rhinorrhea
was the only symptom significantly higher in RV-positive
children as compared to patients with infections caused
by other respiratory viruses (Table 2). Increased respira-
tory rate was found in more than one third of the patients
with a single or mixed infection with RV, as well as in
infections caused by other viruses. The clinical features of
children having a co-infection with RV and other respira-
tory virus were no statistically different from those with
single RV infections. Also, no significant difference was
found between patients infected with RV species A or C.
RV-B was excluded from the analysis given that a single
child was infected with this virus.
In 92.7% of the RV-positive patients with LRTI the
diagnosis of pneumonia was confirmed radiologically, as
it was in 94.5% of children positive for other viruses
(Table 3). Children with RV had fever >38°C and in-
creased respiratory rate more frequently than children
with any other respiratory virus. This was true for single
and mixed RV infections. Other major signs detected
upon examination of RV-positive patients were thora-
coabdominal dissociation, and intercostal retraction. Ac-
cording to the Silverman-Anderson score there was no
difference between children with RV or any other virus;
76.4% of the patients with RV co-infections and 82.3% of
RV single infections had a score between 1 and 3. In the
chest-X ray examination, 78.1% of the RV-positive
patients had signs of interstitial pneumonia; these per-
centages were similar for RV-single infections. There
was no difference between the clinical signs observed in
children infected with either RV-A or RV-C.
Genetic diversity of RV
The phylogenetic trees in Figure 2 depict the wide distri-
bution of 5′-UTR sequences of the RV-A and RV-C
Table 1 Frequency of RV infections in children with upper and lower respiratory tract infections



























≤12 (n=126) 26 (20.6) 18 (14.3) 8 (6.3) 12 (9.5) 9 (7.1) 3 (2.4) 1 (0.8) 7 (5.5) 6 (4.8) 1 (0.8) 0.233
12-60 (n=248) 30 (12.1) 27 (10.9) 13 (5.2) 20 (8.1) 12 (4.8) 8 (3.2) 0 14 (5.6) 11 (4.4) 3 (1.2) 0.269
>60 (n=146) 26 (17.8) 19 (13.0) 7 (4.8) 13 (8.9) 10 (6.8) 3 (2.1) 0 6 (4.1) 5 (3.4) 1 (0.7) 0.096




≤12 (n=127) 22 (17.3) 12 (9.4) 10 (7.9) 9 (7.1) 5 (3.9) 4 (3.1) 2 (1.6) 4 (3.1) 2 (1.6) 2 (1.6) 0.154
12-60 (n=105) 33 (31.4) 22 (20.9) 11 (10.5) 9 (8.6) 6 (5.7) 3 (2.9) 1 (0.9) 13 (12.4) 9 (8.6) 4(3.8) 0.472
> 60 (n=2) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
aThe incidence and percentage of RV genotypes A, B, and C in the population are an underestimate, since the genotype of only 73 (80%) of the 92 RV-positive samples could be determined.
bThe percentage in all cases are referred to the total number of samples.










Figure 1 Seasonal distribution of different RV species in children with upper respiratory tract infections. The number of RV-A, RV-B, RV-C,
and untyped RV-positive samples for each month are shown. The number of samples analyzed and the percentage of RV-positive samples per
month are indicated.
Table 2 Clinical observations in RV-positive children with URTI
Other virus (%) (n = 284) RV-positive (%) (n = 92) p-valuea RV single infection (%) (n = 64) p-valuea
Asthmab 50 (17.6) 19 (20.7) 0.512 14 (21.9) 0.426
Allergic rhinitisb 68 (23.9) 29 (31.5) 0.149 22 (34.4) 0.085
Rhinorrhea 232 (81.7) 83 (90.2) 0.05 57 (89.1) 0.156
Dysphagia 187 (65.8) 50 (55.3) 0.047 34 (53.1) 0.049
Cough 253 (89.1) 84 (91.3) 0.544 58 (90.6) 0.718
Nausea 66 (23.2) 13 (14.1) 0.062 10 (15.6) 0.183
Vomiting 74 (26.1) 12 (13.3) 0.01 7 (10.9) 0.01
Diarrhea 29 (10.2) 7 (7.6) 0.461 4 (6.3) 0.328
Headache 114 (41.5) 20 (21.7) 0.001 14 (21.9) 0.006
Myalgia/Arthralgia 85 (29.9) 11 (12.0) 0.001 9 (14.1) 0.01
Dysphonia 40 (14.1) 14 (15.2) 0.788 11 (17.2) 0.526
Nasal flaring 11 (3.9) 4 (4.3) 0.84 4 (6.3) 0.398
Intercostal retraction 36 (12.7) 10 (10.9) 0.646 9 (14.1) 0.765
Conjunctivitis 24 (8.5) 8 (8.7) 0.942 5 (7.8) 0.867
Xiphoid retraction 10 (2.5) 3 (3.3) 0.905 3 (4.7) 0.657
Thoracoabdominal dissociation 11 (3.9) 2 (2.2) 0.438 2 (3.1) 0.776
Dyspnea 38 (13.4) 11 (12.0) 0.724 10 (15.6) 0.638
Wheezing 53 (18.7) 14 (15.2) 0.453 12 (18.8) 0.987
Fever > =38 146 (51.4) 28 (29.3) 0.0001 17 (26.6) 0.0001
Increased heart ratec 25 (8.8) 3 (3.7) 0.078 2 (3.1) 0.125
Increased respiratory rate - tachypneac 148 (52.1) 39 (42.4) 0.105 28 (43.8) 0.227
ap-values are between overall RV infections or RV in single infection and the presence of other respiratory virus. In bold are statistically significant differences.
bPrevious condition.
cAdjusted by age range.
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Table 3 Clinical observations in RV-positive children with LRTI
Other virus (%) (n = 126) RV-positive (%) (n = 55) p-valuea RV single infection (%) (n = 34) p-valuea
Pneumonia 120 (94.5) 51 (92.7) 0.488 30 (88.32 0.131
Cough 121 (96.0) 50 (90.9) 0.165 32 (94.1) 0.628
Nasal flaring 65 (51.6) 19 (34.5) 0.034 10 (29.4) 0.047
Grunting on exhalation 29 (23.0) 8 (14.5) 0.194 6 (17.6) 0.502
Intercostal retraction 111 (88.1) 45 (81.8) 0.260 28 (82.4) 0.378
Xiphoid retraction 68 (54.0) 14 (25.5) 0.0001 10 (29.4) 0.011
Thoracoabdominal dissociation 51 (40.5) 24 (43.6) 0.691 12 (35.3) 0.583
Fever > =38 37 (29.4) 25 (45.5) 0.036 17 (50.1) 0.024
Increased respiratory rate - tachypneab 94 (75.2) 49 (89.1) 0.037 32 (94.1) 0.0001
ap-values are between overall RV infections or RV in single infection and the presence of other respiratory virus. In bold are statistically significant differences.
bAdjusted by age range.
Figure 2 Phylogenetic trees of clinical viral isolates based on the analysis of 400 nt from the 5′-UTR hypervariable region of the RV
genome. The tree branches of each 5′-genotype in the RV-A and RV-C trees are labeled with a different color; genotype numbering starts at the
gap in the circle and increases counterclockwise. The names of the sequences starting with “gi” correspond to reference strains downloaded from
GenBank and are depicted with grey triangles. The blue squares represent viruses detected in outpatient children, and their names start with the
two initial letters of the city where the sample was collected (CO, Córdoba; MI, Minatitlán; PR, Poza Rica; TB, Tierra Blanca; VE, Veracruz). The red
circles indicate viruses detected in hospitalized children, and the names of the hospitals from which the sample was collected are coded as follows:
DGO, Hospital General de Durango; HCGDL, Hospital Civil de Guadalajara; HGMDF, Hospital General de México, D.F.; HPCDF, Hospital Pediátrico
de Coyoacán, D.F.; GDL, Hospital de Pediatría, IMSS; SLP, Hospital Central de San Luis Potosí. The gray circles in the phylogenetic tree for RV-A
species represent the terminal clades of the tree that were identical to the terminal clades of the tree constructed with full genomic sequences [6]. The
reference strains (gi) that are not contained in the gray circles are marked with a dot at the end of the name, and represent sequences that do not
match with the terminal clades of the reference, full genomic sequences tree. The database of reference strains contained only those viruses with
complete genomic sequences. The numbers after the colors in the vertical bar represent the 5′-genotype of the virus, as described in the -Genetic
diversity of RV- section of results.
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characterized RV strains could be classified into 35 differ-
ent 5′-UTR-based genotypes (5′-genotypes); in this work,
two 5′-genotypes were defined as different when their 5′-
UTR sequence identity was equal or less than 87%, similar
to the cutoff determined for genotypes based on VP1
nucleotide sequences [21]. Seventeen genotypes were
associated with RV-A and 18 with RV-C. Each genotype
included from 1 to 14 different virus strains. In the case of
RV-A, 5′-genotypes were significantly more frequently
found in either hospitalized (genotype 2, p < 0001) or out-
patient (genotype 6, p < 0.001) children, while for RV-C
some 5′-genotypes also associated more frequently with
either URTIs (genotypes 2, p < 0.001 and 18, p = 0.03) or
LRTIs (genotype 6, p < 0.01) (Figure 2). Importantly, the
correlation of 5′-genotypes with reference genotypes de-
fined by full genomic sequences [6] was remarkably high.
Comparison of the phylogenetic trees constructed with
either the 5′-genotypes or the full genomic sequences
showed that 83% (12/72) of the terminal clades present in
the 5′-phylogenetic tree were the same as compared with
the terminal clades of the reference tree (Figure 2). These
results suggest that 5′-genotypes could serve as a simpler
and initial approach to genomically classify RVs. Further
studies need to be conducted to determine if the associ-
ation between some RV 5′-genotypes and the severity of
infection observed in this work holds, or if it is the result
of particular RV genomic types that circulated more fre-
quently in the years that URTI and LRTI samples were
collected.
Discussion
Here, we report the frequency of RV in pediatric patients
with URTI and LRTI in different regions of Mexico. The
frequencies observed in this work are in agreement with
those reported in other studies, in which RV has varied
from 16% to 37% in children with either URTI or LRTI.
Regarding seasonality, RV infections were associated
most frequently to URTI in autumn and early spring, as
reported [22], although it should de noted that the sam-
ples from patients with URTI miss the months from
May to August. On the other hand, a clear peak of
prevalence of the virus in LTRI was observed only
during spring.
An additional respiratory virus was found in about
one-third of the RV-positive patients with either URTI
or LRTI. Detection of several viruses in a high propor-
tion of cases has been a characteristic of respiratory
infections in which a PCR-based diagnostic method was
used. In particular, RV has been found in dual infections
with another respiratory virus in 26% to 63% of cases
[14,18,20]. However, the clinical relevance of detection
of several viruses in pneumonia, and the association with
severe illness is uncertain [2,23-25].Despite technological advances, establishing the cause
of pneumonia remains challenging [26]. In this study
diagnosis of viral pneumonia relied on nasopharyngeal
specimens, what might be misleading since detection of
a virus in the nasopharynx could represent a coinciden-
tal upper-respiratory infection, the asymptomatic pres-
ence of the virus, or a genuine pneumonia pathogen.
Measurement of background prevalence of asymptom-
atic nasopharyngeal viral infections in a healthy control
group and in patients with mild-to-moderate disease
might help to clarify the relevance of this diagnostic
issue at a population level [2]. In most of this type of
studies, but not in all, a higher RV detection among
participants with illness was noted [11,13,19,27-32].
The overall identification of RV was similar but statisti-
cally different between the two patient populations studied.
Children with URTI had a RV rate of 17% as compared to
24.5% in patients with LRTI (p < 0.017). The observation
that the frequency of RV detection in serious respiratory
disease is similar to that observed in mild-to-moderate
illness, or even in asymptomatic cases [11,13,19,27-32], is
intriguing. One would think that if the respiratory disease
caused by RV was more severe than other pathogens, the
percentage of hospitalized children positive for RV should
be significantly higher than that found in outpatient or
healthy children, as observed, for instance, in rotavirus
infections [33]. On the contrary, the incidence of RV should
have to be significantly lower in LRTI as compared to URTI
if the virus infection caused a mild disease. Then, why is
there about the same incidence of RV found in respiratory
infections with different degrees of severity? It is tempting
to hypothesize that specific virus serotypes/genotypes are
preferentially associated to severe or mild clinical symp-
toms. This potential association might be obscured by a
wide diversity of circulating RV serotypes/genotypes with
potentially different intrinsic virulence, such that in differ-
ent children populations similar frequencies of RV infection
are observed but with different clinical outcomes. It cannot
be discarded, however, that mixed infections with bacteria
(not searched in this work) or different host factors could
influence the clinical severity of RV infections, as reported
[34]. Of interest, there have been suggestions since the
earliest epidemiological studies of variation of virulence
among the different RV serotypes [35,36] and, in this line,
we noted in this work that some 5′-genotypes were de-
tected only in either hospitalized or outpatient children.
It would be important to characterize the diversity of
RV genotypes in different parts of the world to deter-
mine if the prevalent viruses vary among regions and in
time, and associate with different severity of the dis-
ease. Identification of this potential association would
have a great impact in the development of prophylactic
measures to control the infection of this very common
pathogen.
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position and diversity of circulating strains in Mexico
and the potential severity of disease associated with both
RV-A and RV-C infections.
Conclusions
This study describes the frequency of detection of rhino-
virus species in children with upper and lower respira-
tory tract infections in Mexico and their genetic
diversity, determined by sequencing the 5′ UTR region
of the viral genome. We report that the 5′UTR sequence
can be useful for an initial approach to determine the
rhinovirus genotypes. We also describe the clinical char-
acteristics of illness associated with specific RV species.
We found that both RV-A and RV-C species were very
frequently found in both hospitalized and outpatient
children and no statistically significant differences were
found in the severity of disease associated with RV-A
and RV-C infections in neither of the two children pop-
ulations. This study underlines the high RV prevalence
and genetic diversity of circulating strains in Mexico and
the potential severity of disease associated with both
RV-A and RV-C infections. This is of particular rele-
vance, since the information about respiratory viruses in
Mexico is very limited, and studies characterizing viruses
circulating in the community level are even scarcer.
Methods
Study populations and clinical samples
Two patient populations were included in this study. The
first was composed of pediatric patients that attended the
private consult in five different cities of the state of
Veracruz, Mexico (Poza Rica, Veracruz, Córdoba,
Tierra Blanca, and Minatitlán). The children were
enrolled in the study if they were younger than 16 years,
clinically diagnosed as having an acute respiratory
infection, with an onset of illness less than one week,
and the parent or guardian signed the informed con-
sent form. Since none of these children required
hospitalization, they were all considered as having
URTIs. From September 2011 to April 2012 nasopha-
ryngeal swabs (rayon-tipped, BD BBL) were collected
from 526 children (male:female ratio, 1.27; median age,
19 months; average age, 39 months; age range, 0–191
months). The second population consisted of children
that required hospital admission with suspected pneu-
monia in four cities (Guadalajara, Mexico City, San
Luis Potosí, and Durango) in different states of Mexico.
These children were all considered to have LRTIs.
Nasal washings were collected from 250 children (male:
female ratio, 1.43; median age, 10 months; average age,
16 months; age range, 1–76 months, with only one
child 143 months old) between March 2010 and April
2011. For both populations, demographic and clinicalinformation was collected. The samples were placed in
vials containing viral transport medium (Microtest M4-
RT, Remel, Lenexa, KS) and sent either to the Institute
of Biotechnology in Cuernavaca (URTI samples) or to
the School of Medicine in Mexico City (LRTI samples)
and stored at −70°C until analyzed. The study was ap-
proved by the institutional review boards of the School
of Medicine and the Institute of Biotechnology of the
National University of Mexico and from the institutional
review board and ethics committee of each participant
hospital. Written informed consent was obtained from
each parent or guardian prior to enrollment.
Nucleic acid extraction and RT-PCR assay
Nucleic acids were extracted from 100 μl of respiratory
specimens using the PureLink Viral RNA/DNA mini kit
(Invitrogen, Carlsbad, CA). RV and other fourteen
respiratory viruses were detected with the Seeplex®RV15
OneStep ACE Detection kit (Seegene, Seoul, South
Korea) following the manufacturer’s instructions. This
diagnostic test detects the following viruses: parainflu-
enza viruses 1, 2, 3, and 4, adenovirus A/B/C/D/E,
human coronaviruses 229E/NL63 and HuCoV-OC43,
rinovirus A/B/C, influenza A, influenza B, respiratory
syncyctial virus-A and -B, human bocavirus 1/2/3/4, hu-
man metapneumovirus, and enterovirus. The RNA
present in the samples positive for RV was reverse tran-
scribed with random hexamers using standard protocols.
PCR was then performed with previously described
primers DK001 and DK004, which target a fragment of
approximately 400 bp of the hypervariable region of the
RV 5′-UTR virus genome [37]. The amplified DNA frag-
ment was purified with the High Pure PCR Product
Purification kit (Roche).
Sequence analysis
The purified PCR products were sequenced in an
Applied Biosystems (Foster City, CA), model 3130xl
apparatus. The sequences obtained were edited using
the Unipro UGENE and Seaview softwares. A database
of RV complete genomes was created using all sequences
available on GenBank until September 2013. BLAST was
performed and the genotype of the RV strains was
assigned based on the first five best scores. The 5′
sequences of the RV strains characterized in this work
were deposited in GenBank with accession numbers
KJ765008 to KJ765123.
Phylogenetic analysis
Multiple sequence alignments were made using
MUSCLE method; maximum likelihood trees were gen-
erated with 1000 repetitions bootstrap using the MEGA
5.2.2 program. To determine the 5′-genotypes, cluster-
ing was made using the cd-hit-test at 87% of identity.
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All statistical data analyses were carried out using PASW
statistical software version 18.0 (SPSS Inc.). Significant dif-
ferences between groups were evaluated using chi-square
tests when it was possible, or Fisher’s exact tests when
values were smaller than 25. Associations of demographic
and clinical features of children with a) RV detected versus
other respiratory virus and, b) RV-A versus RV-C, were
examined using logistic regression. To determine the 5′-
genotypes that were significantly enriched for RV-A or
RV-C, the probability of randomly selecting different viral
strains in each 5′-genotype was calculated by a combina-
torial approach. In all statistical analysis p-values <0.05
were considered statistically significant.
Consent
Written informed consent was obtained from each
parent or guardian prior to enrollment in the study.
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